{"title":"Autophagy in testicular physiology and male fertility: Mechanisms, dysregulation, and translational opportunities.","authors":"M F A Al Salman, S O Ekeuku, K Y Chin","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Autophagy is a highly conserved intracellular degradation pathway that plays a central role in maintaining testicular homeostasis and male reproductive function. This review summarises recent advances in the understanding of autophagy in the testis, with particular emphasis on its roles in Sertoli cells, Leydig cells, and germ cells, as well as its regulatory mechanisms and implications for male infertility. Autophagy contributes to key processes, including spermatogenesis, spermiogenesis, blood-testis barrier integrity, and steroidogenesis, through coordinated organelle turnover and cellular remodelling. Core regulatory pathways such as mTOR, AMPK, PI3K/Akt, and oxidative stress-responsive signalling dynamically controls autophagic flux in response to metabolic and environmental cues. Emerging evidence highlights extensive molecular crosstalk between autophagy, apoptosis, ferroptosis, and ubiquitin-mediated proteostasis, with oxidative stress serving as a central upstream regulator. Dysregulation of autophagy, whether through impaired flux or excessive activation, is strongly associated with male infertility phenotypes, including azoospermia, oligozoospermia, and asthenozoospermia. These effects are driven by defects in germ cell development, mitochondrial function, and hormonal balance, and are further exacerbated by environmental toxicants, lifestyle factors, and ageing. Although autophagy-related proteins such as microtubule-associated protein 1 light-chain 3, p62, and Beclin-1 show promise as biomarkers, their clinical application remains limited by challenges in accurately measuring autophagic flux and context-dependent interpretation. Therapeutic modulation of autophagy using pharmacological agents and antioxidants represents a promising but complex strategy that requires precise, context-specific application. Overall, this review underscores the dual role of autophagy in male fertility and highlights the need for improved biomarkers and translational approaches.</p>","PeriodicalId":48723,"journal":{"name":"Malaysian Journal of Pathology","volume":"48 2","pages":"257-266"},"PeriodicalIF":1.1,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148867138","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Comparison of adverse events of three anti-VEGF drugs for the treatment of age-related macular degeneration.","authors":"A Rosito, S Caranti, R Verna","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Age-related macular degeneration (AMD) is one of the leading causes of irreversible central vision loss among elderly individuals in developed countries. The neovascular form of AMD is currently treated with intravitreal anti-vascular endothelial growth factor (anti-VEGF) agents, particularly ranibizumab, aflibercept, and bevacizumab. Although these therapies significantly improve visual outcomes, repeated intravitreal administration requires continuous monitoring of ocular and systemic adverse events. This review compares the safety profiles of the three principal anti-VEGF agents used for AMD treatment through analysis of pharmacovigilance data, regulatory reports, and major clinical trials. Particular attention is dedicated to ocular complications, systemic thromboembolic events, and the implications of off-label bevacizumab use. Current evidence suggests an overall comparable efficacy and safety profile among the three agents, although Bevacizumab requires stricter preparation and monitoring protocols because of its off-label use. Pharmacovigilance remains essential for identifying safety signals, supporting regulatory decisions, and optimising therapeutic strategies in ophthalmology.</p>","PeriodicalId":48723,"journal":{"name":"Malaysian Journal of Pathology","volume":"48 2","pages":"267-276"},"PeriodicalIF":1.1,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148867198","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Fungal ball-type maxillary sinusitis associated with Penicillium species: A case report and management perspective.","authors":"A F Abdul Wahab, H S Gendeh, F D Zahedi","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Penicillium is a diverse genus of fungus that widely exists in the environment and is often non-pathogenic. Only a handful of literature have reported its association as a cause of infection in humans. Here, we report a case of a Penicillium maxillary sinus fungal ball in an elderly man complaining of chronic headache, progressive unilateral nasal blockage and post-nasal drip. The role of Penicillium in a fungal ball and management are further discussed.</p>","PeriodicalId":48723,"journal":{"name":"Malaysian Journal of Pathology","volume":"48 2","pages":"331-335"},"PeriodicalIF":1.1,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148867273","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
N S Rahim, N A Abdullah, H Abdul Rahman, S Z Omar, H H Siah, A Talib, G C Tan, L J Tan, Y P Wong, K A Zainun, S Adzman
{"title":"Best practice guidelines for standardised placental pathology reporting: A recommendation by perinatal pathology working group, Chapter of Perinatal and Paediatric Pathology, College of Pathologists, Malaysia.","authors":"N S Rahim, N A Abdullah, H Abdul Rahman, S Z Omar, H H Siah, A Talib, G C Tan, L J Tan, Y P Wong, K A Zainun, S Adzman","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Placental pathology provides critical diagnostic, prognostic and clinicopathological insights into maternal-foetal outcomes. While frequently discarded post-delivery, macroscopic and histopathological evaluation can clarify adverse outcomes, including stillbirth, neonatal death, prematurity, foetal growth restriction, hydrops, infection and complicated multiple gestations. This paper outlines a standardized framework for placental examination by covering rationale, indications, specimen handling, sampling and reporting designed for universal implementation across all public, private and academic healthcare facilities. To optimise institutional resources, a phased, indication-based approach is recommended initially, prioritising cases most likely to influence clinical management, parental counselling and future pregnancy care. Pre-analytical optimisation, which includes proper specimen handling, adequate fixation, representative sampling and complete clinical history, is essential to maximize diagnostic yield nationwide. We propose a structured reporting proforma aligned with the current Amsterdam Consensus Classification, including a dedicated section for multiple gestations. This standardises reporting across key pathophysiological domains: maternal vascular malperfusion (MVM), foetal vascular malperfusion (FVM), infections, inflammatory/immune lesions and villous developmental abnormalities. Finally, contextual ancillary investigations are discussed. Ultimately, establishing a unified, cross-sector national placental pathology service holds the potential to significantly improve the audit of adverse perinatal outcomes and elevate maternal-foetal care.</p>","PeriodicalId":48723,"journal":{"name":"Malaysian Journal of Pathology","volume":"48 2","pages":"203-227"},"PeriodicalIF":1.1,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148867161","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The evolving role of pathology in early triple-negative breast cancer in the era of immunotherapy.","authors":"H M Rosli, R R Md Zin, N F Ab Muin, I Rosli","doi":"","DOIUrl":"","url":null,"abstract":"<p><p></p>","PeriodicalId":48723,"journal":{"name":"Malaysian Journal of Pathology","volume":"48 2","pages":"337-338"},"PeriodicalIF":1.1,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148867374","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
M Y Chin, G C Tan, U M J Ungku Mohsin, M K Lee, K Y Tshai, S B Selvam, K N Ting
{"title":"Development of a histological grading system for assessing microplastic-induced structural damage in rat aorta, trachea, and bladder tissues following acute exposure.","authors":"M Y Chin, G C Tan, U M J Ungku Mohsin, M K Lee, K Y Tshai, S B Selvam, K N Ting","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Microplastic (MP) exposure has increasingly been associated with tissue-level impact in toxicology studies, including inflammatory changes and histopathological injury in aquatic and mammalian models. However, there is currently no consistently developed histological scoring approach for assessing the structural damage across different tissue types induced by MPs following acute exposure. This study aimed to develop and apply a semi-quantitative histological scoring framework to investigate the histological alterations of polyethylene terephthalate (PET) MPs in Sprague-Dawley rat aorta, trachea, and bladder ex vivo.</p><p><strong>Materials and methods: </strong>Rat tissues were excised and incubated for 22 to 24 hours at 4°C with different concentrations of PET particles (0.3 - 5.0 mg/mL). Trachea and bladder tissues were processed for haematoxylin and eosin staining, whereas aorta sections were stained using CD31 immunohistochemistry to assess the endothelial integrity. Images were randomised and scored independently by three blinded observers using tissue-specific grading criteria for aorta endothelium, tracheal epithelium, and bladder urothelium.</p><p><strong>Results: </strong>Across the three tissues, the scoring system suggests organ-specific differences in terms of sensitivity to acute exposure, with bladder urothelium appearing as the most structurally vulnerable under the tested conditions.</p><p><strong>Conclusion: </strong>This method provides a structured framework for screening MPs-induced tissue damage and may improve reproducibility in histological evaluation of tissue structural integrity.</p>","PeriodicalId":48723,"journal":{"name":"Malaysian Journal of Pathology","volume":"48 2","pages":"277-292"},"PeriodicalIF":1.1,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148867239","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
P Bala Krishnan, K Y Yong, T F G Chua, S Armon, A Mat Ripen
{"title":"Hodgkin lymphoma mimicking the IgG4-related disease: A diagnostic pitfall.","authors":"P Bala Krishnan, K Y Yong, T F G Chua, S Armon, A Mat Ripen","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>This is a diagnostically challenging case that concerns a 29-year-old man with an eight-year history of right-sided neck swelling. The magnetic resonance imaging (MRI) of the neck revealed multiple well-encapsulated, lobulated, matted right cervical lymphadenopathy. He reported significant weight loss, but denied shortness of breath, altered bowel habits, or bone pain. His initial investigations revealed a normocytic hypochromic anaemia, mild leukocytosis, and thrombocytosis. The initial histological findings showed many IgG4-positive plasma cells, but lacked stromal fibrosis, granuloma, obliterative phlebitis, or malignant cells. In addition, the IgG4+/IgG plasma cell ratio was only about 20%. The serum IgG4 subclass was raised at 258 mg/dl, along with a raised serum IgG1 subclass at 3630 mg/dl. His bone marrow aspirate findings showed reactive plasmacytosis without marrow infiltration or acute leukaemia. Multiple myeloma was excluded by the absence of paraproteins in the serum and urine electrophoresis. A working diagnosis of probable IgG4-RD was made, and he was treated with glucocorticoids and azathioprine. However, the neck mass did not resolve, and the serum globulin was persistently high, ranging from 75 g/l to 95 g/l. A repeat biopsy of the neck swelling demonstrated Hodgkin lymphoma (HL) with mixed cellularity, and the Epstein-Barr virus (EBV) RNA-in-situ hybridisation was negative. He was started on chemotherapy and achieved complete remission, with an episode of relapse 9 months later. Salvage chemotherapy was initiated and is currently awaiting haematopoietic stem cell transplantation. This case highlights the need for repeated histopathological evaluation and reflects the complexity and overlap between HL and IgG4-RD.</p>","PeriodicalId":48723,"journal":{"name":"Malaysian Journal of Pathology","volume":"48 2","pages":"319-324"},"PeriodicalIF":1.1,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148867370","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"HER2-low breast carcinoma: A newly recognised entity driving paradigm shifts in precision treatment.","authors":"S F Chiew, L M Looi, S W Chang, P L Cheah","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Recent clinical trials have shown the usefulness of anti-HER2 (Human epidermal growth factor receptor 2) treatment in the newly described \"HER2-low\" subset of breast carcinoma, offering added treatment option to the once considered non-responders. This study aimed to identify this important new subset's demographic and pathological features in a Malaysian cohort.</p><p><strong>Materials and methods: </strong>All newly and recurrent histopathologically-diagnosed invasive breast carcinomas encountered at the University of Malaya Medical Centre (UMMC) between January 2018 to December 2023 that satisfied inclusion criteria were enrolled. Patient demographics were retrieved from the histopathological requests. All haematoxylin and eosin (H&E) stained, immunohistochemically (IHC) stained HER2, oestrogen receptor (ER) and progesterone receptor (PR) together with HER2 amplification assayed by dual-colour dual-hapten in situ hybridisation (DDISH) sections for all cases were reviewed for histological type, histological grade, pathological stage, hormone receptors (HR encompassing ER and PR) and HER2 status.</p><p><strong>Results: </strong>710 invasive breast carcinomas were finally included. HER2-low was noted in 48.2% (n = 342) of the carcinomas, while 191 (26.9%) were in the conventional HER2 positive category. HER2-low carcinomas demonstrated significantly lower (Grade 1 and 2) histological grade and were more commonly hormone status positive compared with both HER2 positive and negative groups.</p><p><strong>Conclusion: </strong>HER2-low constituted a significant number of breast carcinomas and appears to have its own unique features. The recognition of this category has expanded anti-HER2 treatment options to an additional 48% of breast carcinomas.</p>","PeriodicalId":48723,"journal":{"name":"Malaysian Journal of Pathology","volume":"48 2","pages":"293-303"},"PeriodicalIF":1.1,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148867433","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"HER2 ultralow in metastatic breast cancer: Diagnostic boundaries in the era of antibody-drug conjugates.","authors":"E S Ch'ng","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The introduction of antibody-drug conjugates (ADCs) such as trastuzumab deruxtecan (T-DXd) has challenged the traditional binary classification of HER2 in breast cancer. Evidence from the DESTINY-Breast04/06 and DAISY trials demonstrates clinically meaningful antitumour activity across a continuum of HER2 expression, including HER2-low and HER2-ultralow categories, while efficacy in HER2-null tumours remains uncertain. Despite this graded biological response, regulatory criteria remain categorical, requiring detectable membrane staining for treatment eligibility and excluding IHC 0 tumours. Pathologists face diagnostic challenges at the null-ultralow boundary, where conventional immunohistochemistry (IHC) assays operate near their analytical limits, reproducibility is constrained, and inter-observer variability is high. Pathologists should exercise caution when assigning IHC 0, and practical measures such as reflexive re-evaluation, re-staining of alternative blocks, and referral to high-sensitivity laboratories are recommended. Transparent communication of analytical uncertainty is essential to optimise patient access to ADC therapy.</p>","PeriodicalId":48723,"journal":{"name":"Malaysian Journal of Pathology","volume":"48 2","pages":"229-232"},"PeriodicalIF":1.1,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148867266","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Navigating the legal and regulatory landscape for digital pathology in Malaysia.","authors":"N R Abdul Rahman, N H Othman, E S Ch'ng","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The transition from traditional microscopy-based diagnostic workflows to digital pathology for primary diagnosis necessitates a robust understanding of the applicable legal and regulatory frameworks. This review synthesises the multi-layered regulatory landscape governing digital pathology adoption in Malaysia. Key statutory and professional requirements are examined, including the Medical Device Act 2012 for system registration; MS ISO 15189 and STR 2.2 for laboratory accreditation and clinical validation; and the Malaysian Medical Council's 2024 Telemedicine Guideline for its implications on telepathology practice. In addition, the integration of digitised slides into formal medical records is considered under the Private Healthcare Facilities and Services Regulations 2006, alongside data privacy obligations under the Personal Data Protection Act 2010 and evidentiary admissibility requirements under the Evidence Act 1950 Malaysia. This review underscores that safe and legally compliant implementation of digital pathology requires rigorous system validation, strict data security protocols, appropriate institutional credentialing, and comprehensive audit trail maintenance.</p>","PeriodicalId":48723,"journal":{"name":"Malaysian Journal of Pathology","volume":"48 2","pages":"233-239"},"PeriodicalIF":1.1,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148867415","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}